Glowing dye could help surgeons spot hidden ovarian cancer

NCT ID NCT05804370

Recruiting now Diagnosis Sponsor: NX Development Corp Source: ClinicalTrials.gov ↗

Summary

This study is testing a drug called Gleolan that makes ovarian cancer tumors glow under blue light during surgery. The goal is to help surgeons see and remove more cancerous tissue than they can with standard methods alone. The trial will involve about 170 women with suspected new or returning ovarian cancer who are scheduled for tumor-removal surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Luminis Health Anne Arundel Medical Center
TERMINATED

Annapolis, Maryland, 21401, United States
Mayo Clinic Arizona
RECRUITING

Phoenix, Arizona, 85054, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Mayo Clinic Methodist Campus
RECRUITING

Rochester, Minnesota, 55905, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Mount Sinai
RECRUITING

New York, New York, 10128, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
University of Maryland
RECRUITING

Baltimore, Maryland, 21201, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
WellSpan Health
RECRUITING

York, Pennsylvania, 17403, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

OVARIAN CANCER